Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance

Abstract : Multidrug resistance (MDR) is a major impediment to the success of chemotherapy in many cancer types. One particular MDR mechanism is the inherent or acquired adaptation of the cellular survival pathways that render malignant cells resistant to apoptotic cell death. Since most drugs act through apoptosis, compounds capable of inducing alternative forms of programmed cell death (PCD) can potentially be harnessed to bypass MDR. We investigated two organoruthenium complexes, RAS-1H and RAS-1T, and demonstrated that although they both induced non-apoptotic PCD through ER stress pathways, their modes-of-action were drastically different despite modest structural variations. RAS-1T acted through ROS-mediated ER stress while RAS-1H was ROS-independent. We further showed that they were more efficacious against apoptosis-resistant cells compared to clinical drugs including oxaliplatin. This work provides the basis for underpinning ER stress modulation using metal complexes to bypass apoptosis resistance.
Complete list of metadatas

Cited literature [49 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02365338
Contributor : Christian Gaiddon <>
Submitted on : Friday, November 15, 2019 - 1:19:24 PM
Last modification on : Saturday, November 16, 2019 - 1:30:39 AM

File

ChemSci2016Chow_et_al.pdf
Publication funded by an institution

Identifiers

Collections

Citation

Mun Juinn Chow, Cynthia Licona, Giorgia Pastorin, Georg Mellitzer, Wee Han Ang, et al.. Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance. Chemical Science , The Royal Society of Chemistry, 2016, 7 (7), pp.4117-4124. ⟨10.1039/c6sc00268d⟩. ⟨inserm-02365338⟩

Share

Metrics

Record views

76

Files downloads

14